ENTRAL nervous system injuries can lead to a debilitating loss of sensorimotor function and are often irreparable. In contrast to the peripheral nervous system, the CNS lacks the ability for spontaneous repair or regeneration of damaged axonal projections. This inability is partially related to the inhibitory postinjury environment within which CNS neurons are attempting to maintain or reextend damaged neurites. Many factors lead to the inhibitory nature of the extracellular environment after CNS trauma, including formation of glial-derived scar tissue; release of toxic cytokines by glial cells, inflammatory cells, and damaged neurons; physical disruption of axonal fiber tracts; loss of neurotrophic support from glial cells and surrounding neurons; and a lack of physical support for neurite projections. 3 In the tissue engineering approaches to the repair of CNS injuries, investigators have focused on addressing many of these issues using biomaterials as scaffolds. The ultimate goal is to provide a postinjury environment that is more conducive to neurite outgrowth than that seen in native tissue.
sulfated, linear glycosaminoglycan composed of repeating disaccharide units of ␤-1,4-D-glucuronic acid and ␤1,3-N-acetyl-D-glucosamine. Found ubiquitously in all tissues, HA possesses intrinsic bioactive properties mediated by cell receptors collectively known as hyaladherins. 6, 7, 20 Hyaluronic acid has been used in many medical applications and has been investigated as a potential biomaterial system for tissue engineering. The mechanical properties of native HA, however, can prove to be insufficient for most applications. Recently, a modification of HA-achieved by mixing it with semisynthetic polymers such as methylcellulose-has shown promise in promoting functional recovery in rodent models of SCI. 9 Moreover, thiol modification to generate living polymers as in situ cross-linkable materials for wound repair and tissue engineering have been described in detail. 10, 21, 30, 38, 43 Thus, the goals of the present study were to generate modified HA polymers and to determine their effect on neurite outgrowth enhancement in vitro and recovery from SCI in vivo.
Materials and Methods

Supplies and Equipment
Fermentation-derived hyaluronan was purchased from Clear Solutions Biotechnology, Inc. Human plasma fibrinogen, bovine serum albumin, L-glutamic acid, CaCl 2 , wheat germ agglutinate-HRP, tetramethylbenzidine, and bovine serum thrombin were purchased from Sigma Chemical Co. Poly(ethylene glycol)-diacrylate (MW 3400 D) was purchased from Nektar Therapeutics. Neurobasal medium, N-2 supplement, 7S nerve growth factor, antibioticantimycotic, and L-glutamine were supplied by Invitrogen, Inc. Tissue culture plates (24 wells), syringe filters (5.0 and 0.2 m), and dialysis tubing (8000 MW cutoff) were purchased from VWR Scientific. Rhode Island red chicken eggs were procured from a local private distributor. Sprague-Dawley rats were supplied by Charles River.
Hydrogel Preparation
Hyaluronan was thiolated as previously described, 38 and the thiol groups were used as cross-link sites. Poly(ethylene glycol)-diacrylate was used as a bifunctional electrophilic cross-linker that reacted with the thiol groups via Michael-type addition to form covalently cross-linked hydrogels. To establish a concentration of thiolated HA suitable for neurite outgrowth, gels ranging from 0.2 to 1.25% (wt/vl) were prepared and tested in cell culture for the greatest degree of activity. For these samples, 0.25, 0.375, 0.5, 0.625, 0.9375, 1.25 and 1.5625% (wt/vl) thiolated HA stock solutions were prepared by solubilizing the appropriate amount of HA in neurobasal medium and verifying pH at approximately 7.4. The final thiolated HA-PEGDA (wt/wt) in the gels tested was 0.9 weight percent PEGDA. Stock solutions of PEGDA were prepared at concentrations of 0.9, 1.35, 1.8, 2.25, 3.375, 4.5 and 5.625% (wt/vl) and used to cross-link each of the corresponding thiolated HA solutions (Table 1) . From these preliminary screening experiments, we determined that 0.5% (wt/vl) was the optimal thiolated HA concentration for neurite growth in vitro, within the range tested (data not shown). Thus, this concentration was used in all subsequent cultures.
Fibrinogen was solubilized in Tris-buffered saline (41.3 mM Tris, 137 mM NaCl, 2.7 mM KCl, pH 7.4) at a concentration of 16.67 mg/ml for 4 hours and then dialyzed against Tris-buffered saline overnight. All solutions were filtered through a 5.0-m syringe filter to remove particulates and sterilized through 0.2-m filters. The concentration of the fibrinogen solutions was verified via ultraviolet spectrophotometry (A 280 ) using a molar absorptivity of 5.12 ϫ
, 25 and adjusted to a final value of 8 mg/ml. The final fibrin gel concentration was 4 mg/ml (0.4% wt/vl). Fibrin gels of this concentration have been investigated extensively 11, [32] [33] [34] 37, 40 and were chosen to serve as a control matrix in our experiments.
Gels of each material were formed by placing 400 l of thiolated HA or 250 l of fibrinogen solution in a well of a 24-well tissue culture plate. Cross-linking was initiated on introduction of 100 l of PEGDA or 250 l of thrombin solution, respectively. This process yielded 500-l gels of either 0.5% (wt/vl) thiolated HA or 0.4% (wt/vl) fibrin. These final gel concentrations were specifically chosen as described earlier.
Chick DRG Culture
Embryonic Day 9 (E9) chick DRGs were dissected bilaterally and stored in culture medium until needed. A single DRG was placed in a culture plate well containing fibrinogen or thiolated HA, to which either the thrombin or PEGDA solution was added, respectively. Polymerization occurred around the DRGs, which embedded them within the gels. Medium (500 l) was placed on each fibrin culture subsequent to full gelation (~ 10 minutes). This step was unnecessary for thiolated HA gels, which were prepared in medium. All samples were incubated at 37˚C and in 5% CO 2 for 48, 60, or 192 hours.
Image Analysis
At the end of the culture period, images of the tissue cultures were acquired on a Leica DM IRB inverted light microscope fitted with a MagnaFire SP (Optronics) digital imaging system. The images were analyzed using an ImagePro Plus (Media Cybernetics) software package to quantify the extent of neurite outgrowth. Because of an apparent similarity in refractive index between the neurites and surrounding gels, it became difficult to obtain images of both structures at once. Therefore, two separate phase-contrast images were acquired using two different filters. The images were superimposed on each another to yield a final quantifiable image.
Perimeters were formed around the DRG body and neurite extensions using a best-fit circle algorithm to delineate the edges of each (Fig. 1) . Briefly, 20 points were randomly chosen to demarcate the tissue edges, which were then used by the software to compute a circle of equivalent average radius. This procedure formed an anulus, the radius of which was used as a metric of neurite growth. Because of the careful manipulation of the gels needed for processing, a blinded analysis was not possible.
Spinal Cord Injury Model
All animal experiments were performed with the full approval of the Animal Care Committee at Barrow Neurological Institute of St. Joseph's Hospital and Medical Center. Adult male Sprague-Dawley rats (weighing 250-350 g) were anesthetized with an intramuscular injection of ketamine/xylazine/acepromazine (50/7/1 mg/kg). Using fluoroscopy, the T9-10 vertebrae were identified and marked using a methylene blue dye injection. Transcranial stimulation was used to elicit MEPs, which were recorded unilaterally from the contralateral gastrocnemius muscle. 26, 27 Briefly, a train of three stimulating currents (333 Hz, 10-100 mA, 0.3-msec duration) was applied to the scalp overlying the sensorimotor cortex, and bipolar recording electrodes inserted into the contralateral gastrocnemius muscle were used to record the MEPs. A grounding electrode was placed in the skin just rostral to the recording electrodes. The average response from 20 sets of stimulation was used to analyze the peak amplitude and latency from the first potential in each animal. Under sterile conditions, T9-10 laminectomies were performed, and the spinal cord was transected using a scalpel and microscissors. An operating microscope was used to ensure that transection of the spinal cord was complete. After transection, another set of MEPs was recorded to verify that the transection was complete.
In the experimental rats either a 0.5 or 1% cross-linked HA hydrogel compound was placed at the transection site. The 0.5% cross-linked HA was associated with better neurite outgrowth in vitro, but the rationale for using the 1% concentration in the in vivo experiments was its higher viscosity, which allowed the polymer to remain at the site of transection better than the 0.5% thiolated HA concentration. No compound was placed in control animals at the transection site.
After transection, all rats were allowed to recover and were allowed access to food and water. Their bladders were expressed manually twice daily until spontaneous bladder expression returned. For 3 days after transection, the rats were treated with 0.5% Polyflex antibiotic delivered intraperitoneally.
Motor function was assessed in a blinded fashion using the BBB scale 2 on a weekly basis for an 8-week period. At that time the animals were anesthetized with an intraperitoneal injection of ketamine/xylazine/acepromazine and MEPs were again recorded at the same stimulation level as immediately after spinal cord transection. Because the recovery of the MEPs was absent in most animals undergoing spinal cord transection, the latencies were not used for comparison.
Histological Testing
After MEP testing, each rat underwent a T-12 laminectomy. A glass micropipette was used to inject 500 nl of 1% wheat germ agglutinate-HRP dissolved in saline into the midline of the spinal cord at T-12. The rats were allowed to recover for 48 hours before being reanesthetized prior to perfusion. The animals were sequentially perfused transcardially with warmed saline, 3% paraformaldehyde solution, 15% sucrose, and 30% sucrose solutions.
The brains and spinal cords were removed and placed in 30% sucrose solution for 48 hours. The midbrain and spinal cord of each rat was frozen in cryopreservative (Tissue-Tek) and sliced at 40-m increments on a cryostat (Leica). The slices were processed to evaluate for the presence of HRP in the red nucleus and in spinal cord nuclei and tracts. 24 Briefly, the slices were washed in acetate buffer, placed in tetramethylbenzidine solution (0.05% in acetate buffer), followed by sodium nitroferricyanide (0.1% in acetate buffer). The slices were mounted on gelatin-subbed slides and counterstained with 0.1% thionin. Dark-field microscopy was used to observe the presence of HRP-stained cells in the red nucleus or axons rostral to the transection site in the spinal cord.
Results
Dorsal Root Ganglion Explants
After 48 hours of incubation, samples grown in crosslinked HA hydrogels exhibited more than a 50% increase in mean neurite length compared to fibrin (Fig. 2) . Moreover, the overall morphological characteristics of the extensions within each material were distinct. Cultures in cross-linked HA hydrogels consistently demonstrated fine, uniform arrays of neurite outgrowth, whereas some fibrin samples appeared to possess thick processes that extended in a few arbitrary directions. Over time these processes collapsed and degraded more readily when in fibrin than in the cross-linked HA hydrogels (Fig. 3) . No fibrin cultures possessed intact neurites after approximately 60 hours. In contrast, DRGs cultured in the HA samples continued to extend neurites throughout the entire 8-day culture period (Fig. 4) . When compiled, the mean neurite halo radius of the explants at 48 hours was significantly greater when cultured in 0.5% thiolated HA than in fibrin (Fig. 5) .
Spinal Cord Injury Model
Fifteen rats were used to determine the efficacy of the HA polymer in promoting axonal regrowth and functional recovery after SCI. Four rats that underwent sham surgeries showed no motor function deficits, and the HRP staining in their red nucleus neurons was robust (data not shown). In the three control rats no HRP staining was demonstrated rostral to the transection site, including the red nucleus. Four rats each were in the 0.5 and 1.0% HA polymer groups. Compared with the control rats, there was no difference in the functional outcome for either polymer group at 8 weeks as measured on the BBB Scale (Fig. 6) . Likewise, there were no differences in the amplitude of the MEPs between the control and 1% thiolated HA groups 8 weeks after SCI (Figs. 7 and 8 ). Analysis showed no HRP staining in the spinal cord rostral to the transection site (Fig. 9 ) or in the red nucleus in either the control or cross-linked HA group. In each animal, a signif- icant amount of fibrosis at the transection site prevented neuritic outgrowth.
Discussion
The aforedescribed experiments represent the initial investigation of the ability of cross-linked thiolated HA-PEGDA to induce and support neuritic outgrowth from DRG cultures and to promote recovery from spinal cord transection. Compared with fibrin control matrices, crosslinked thiolated HA-PEGDA gels promoted a significant increase in the mean length of neurites. We did not observe any effect of this polymer on the histological, electrophysiological, or behavioral recovery of spinal cord function following spinal cord transection in rats. We believe that the profound inflammatory response seen at the transection site contributed to the lack of recovery in this model and that the polymer in its current form was unable to overcome this inflammatory response. Although this polymer was associated with no differences in the functional recovery of experimental rats compared with control rats after complete transection of the thoracic spinal cord, the robust response in the DRG cultures is encouraging. In addition to the increase in neurite length, neurites in these cultures sprouted substantially earlier than fibrin controls (unpublished observation). The morphological nature of the neuritic outgrowth in the fibrin matrices was also distinctly variable. A substantial proportion of the cultures exhibited a highly fasciculated, trunklike pattern of neuritic growth. These observations were coincident with a noticeable perimeter of fibrin degradation that surrounded the DRG.
In previous studies a similar degradation pattern observed has been attributed to proteolytic digestion of the fibrin fibrils by the advancing neuritic growth cones. 11 Herbert et al. 11 found that after mild mechanical perturbation of the culture plates (that is, gentle vibrations) DRG extensions freely oscillated within a zone of degraded fibrin. Furthermore, when exposed to drastic mechanical perturbations, the neurites disconnected and recoiled from their adhesion points within the outer, intact fibrin. These observations are consistent with the patterns found in the present study. In fibrin cultures that were moved from the incubator to the microscope stage or moved about on the stage before 60 hours of incubation, neurites adhered only to the matrix material that lay outside the zone of prote- olytic degradation. After 60 hours of incubation, the fibrin cultures became so susceptible to outside mechanical perturbations that gentle manipulation of the culture dishes disrupted most or all neuritic outgrowth.
Herbert et al. 11 found that degradation of fibrin matrices could be mitigated by including plasmin inhibitors or plasminogen-activation inhibitors. When DRGs were cultured within the fibrin matrices, however, there was also a direct inhibitor concentration-dependent reduction of neuritic length. Based on these data, the stabilization of fibrin matrices in this manner appears to be a delicate balance between that which is necessary to preserve the mechanical integrity of the matrix and that which is most conducive to neuritic outgrowth. By contrast, the neurites in the crosslinked thiolated HA-PEGDA matrices exhibited no signs of instability throughout the culture period. Modification of HA with hydrazide chemistry effectively converts a fraction of the glucuronic acid carboxyl groups to thiol-containing hydrazides. 38 The thiolated HA can be slowly cross-linked into biocompatible, slowly bioerodable hydrogels via oxidative formation of disulfide bonds 38 or more rapidly by conjugate addition using bifunctional electrophiles. 21, 43 The modified material system and cross-linking mechanism have been detailed elsewhere. 10, 21, [28] [29] [30] 38, 43 This ability to stabilize the HA chains covalently provides a material system with improved mechanical properties, which can be tailored to specific applications. One benefit of this modification was more Hydrogels and recovery from neural injury rapid cross-linking compared with unmodified HA. Of course, cross-linking was concentration dependent, which created a discrepancy between the optimum concentration for neuritic growth found in the in vitro experiments (0.5%) and the ability of this same concentration to crosslink adequately in vivo. This discrepancy may have contributed to the lack of response in vivo, but more studies are needed to answer this question.
Fibrin was chosen as a control and benchmark substrate for the DRG cultures for a number of reasons. It is a major component of the coagulation cascade and is a primary participant in wound-healing responses. This native extracellular matrix protein provides a temporary scaffold for blood clotting and cellular infiltration of an injury site, eventually leading to healing and regeneration of tissue. Commercial versions of fibrin glues have been used clinically for years to treat various conditions. They have been used as a universal tissue and wound sealant 5, 16, 19, 22, 31, 35, 39 and to repair neural injuries ranging from dural lesions to skeletal (skull and vertebral) defects and nerve anastomoses. 18 Fibrin-based biomaterial systems have long been investigated for use as tissue-engineering scaffolds, including systems focused on neural applications. 4, 11, 12, 14, 15, 17, 23, 28, [32] [33] [34] 36, 37, 40, 42 Given the detailed characterization of fibrin as a neural matrix for tissue engineering and its widespread use, both clinically and experimentally, we believe that it was a suitable control material.
When applied in vivo, CNS injury treatments based on biomaterial systems will be required to support neuritic integrity for time spans adequate to permit the formation of healthy native replacement tissue. As our studies show, covalently cross-linked thiolated HA provided structural support for complex arrays of neuritic extensions for culture periods longer than 8 days. Indeed, the cessation of these cultures was necessary only because the viability of the growth medium in the wells was insufficient for tissue growth beyond these time points. The gels, while still structurally stable enough to support neurites, were too weak to endure the application of a fresh medium. Furthermore, variants of this thiolated HA material system have been tested in various in vivo and in vitro models for as long as 8 weeks (see the more recent papers, including the vocal fold work by Hansen et al., 10 Zheng and colleagues 43 and others 41 ). In vivo the cross-linked HA hydrogel conferred no benefit on functional, electrophysiological, or histological recovery after spinal cord transection. A significant amount of fibrosis at the site of transection and polymer placement was apparent as early as 7 days postinjury (data not shown). Because the dura mater could not be repaired after transection, the amount of fibrosis was most likely greater than when the dura is intact. Thus, we believe that the polymer was degraded during the inflammatory response soon after transection. It is well established that a strong inflammatory response occurs after initiation of the secondary cascade in SCI. 1, 8 Unless this response is inhibited, the resulting environment leads to strong inhibition of axonal regeneration. Although the cross-linked HA hydrogel effectively promoted neuritic outgrowth in an in vitro culture system, it could not overcome this inhibition in vivo. To overcome this inhibition, compounds that antagonize the inflammatory response, such as 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors or FK506, need to be integrated in the polymer. 28 The cross-linked HA hydrogel that we developed can be conjugated with various molecular compounds. Therefore, future studies will need to be focused on identifying agents that limit this inflammatory response and promote axonal regrowth. 
Conclusions
Analysis of our data shows the ability of a cross-linked HA hydrogel to enhance and support neuritic outgrowth from chick DRGs and highlights the feasibility of these matrices as neural scaffolds for tissue engineering. Moreover, the findings suggest that the innate bioactivity of this material may begin to address many of the inhibitory extracellular environment characteristics found in CNS injury sites. The cross-linked HA hydrogel was unable to overcome the strong inflammatory response induced by spinal cord transection. Therefore, future studies will be focused on incorporating antiinflammatory agents to help inhibit this response.
